4/18
04:09 pm
lgvn
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]
Medium
Report
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]
4/18
04:05 pm
lgvn
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
Medium
Report
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
4/17
08:10 am
lgvn
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds [Yahoo! Finance]
High
Report
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds [Yahoo! Finance]
4/17
08:00 am
lgvn
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
High
Report
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
4/15
10:10 am
lgvn
Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]
High
Report
Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]
4/15
08:39 am
lgvn
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC) [Yahoo! Finance]
High
Report
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC) [Yahoo! Finance]
4/15
08:30 am
lgvn
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
High
Report
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
4/11
05:20 pm
lgvn
Longeveron Announces Closing of $5.2 Million Public Offering [Yahoo! Finance]
High
Report
Longeveron Announces Closing of $5.2 Million Public Offering [Yahoo! Finance]
4/11
05:17 pm
lgvn
Longeveron Announces Closing of $5.2 Million Public Offering
High
Report
Longeveron Announces Closing of $5.2 Million Public Offering
4/8
02:31 pm
lgvn
Longeveron Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
Medium
Report
Longeveron Announces Pricing of $5.25 Million Public Offering [Yahoo! Finance]
4/8
02:15 pm
lgvn
Longeveron Announces Pricing of $5.25 Million Public Offering
High
Report
Longeveron Announces Pricing of $5.25 Million Public Offering
4/8
12:00 pm
lgvn
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
4/8
10:25 am
lgvn
Longeveron stock rallies 75% amid public offering, business update [Seeking Alpha]
High
Report
Longeveron stock rallies 75% amid public offering, business update [Seeking Alpha]
4/8
08:49 am
lgvn
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals [Yahoo! Finance]
High
Report
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals [Yahoo! Finance]
4/8
08:30 am
lgvn
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
High
Report
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
3/19
04:19 pm
lgvn
Longeveron Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
High
Report
Longeveron Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
3/19
04:01 pm
lgvn
Longeveron Announces 1-for-10 Reverse Stock Split
High
Report
Longeveron Announces 1-for-10 Reverse Stock Split
2/28
09:33 am
lgvn
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Longeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/27
04:10 pm
lgvn
Longeveron Reports Year-End 2023 Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Longeveron Reports Year-End 2023 Results and Provides Corporate Update [Yahoo! Finance]
2/27
04:05 pm
lgvn
Longeveron Reports Year-End 2023 Results and Provides Corporate Update
Low
Report
Longeveron Reports Year-End 2023 Results and Provides Corporate Update
2/21
04:05 pm
lgvn
Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
Medium
Report
Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024
1/29
08:09 am
lgvn
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™ [Yahoo! Finance]
High
Report
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™ [Yahoo! Finance]
1/29
08:00 am
lgvn
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™
High
Report
Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™